Ado-trastuzumab emtansine (T-DM1) induced pulmonary toxicity: A retrospective analysis of a single institution experience

Authors :: Anne F. Schott
Heidi Egloff
Kelley M. Kidwell
Source :: Journal of Clinical Oncology. 36:e13004-e13004
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: e13004Background: T-DM1 is an antibody drug conjugate with proven efficacy in metastatic breast cancer for progressive disease refractory to trastuzumab. FDA prescribing information cites a pneumon...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Antibody-drug conjugate
Ado-trastuzumab emtansine
Pulmonary toxicity
business.industry
medicine.disease
Metastatic breast cancer
Refractory
Trastuzumab
Internal medicine
medicine
Single institution
skin and connective tissue diseases
business
Progressive disease
medicine.drug

Full Text Access

Tools